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The aim of the present study was to examine whether the level of dietary cis fatty acid (cFA), or the isomers (trans or cis) and/or the saturation of
the fatty acids at high dietary fat levels altered the intracellular glucose metabolites and certain regulatory enzyme activities in the skeletal muscle
and liver of rats. The animals were fed for 30 d on either a recommended control diet (7% cFA, w/w) or a high-fat diet (20% fatty acids, w/w).
The high-fat diet was enriched with either cFA, trans fatty acid (tFA), a moderate proportion of saturated fatty acid (MSFA), or a high proportion
of saturated fatty acid (HSFA). The most striking findings were observed in the gastrocnemius muscle with a HSFA diet. There was a significant
increase in glucose-6-phosphate (306%), glucose-1-phosphate (245%), fructose-6-phosphate (400%), fructose-1,6-bisphosphate (86%), glyceral-
dehyde-3-phosphate (38%), pyruvate (341%), lactate (325%), citrate (79%) and the bisphosphorylated sugars as compared with the cFA diet.
These changes were paralleled by an increase in muscle triacylglycerol content (49%) and a decrease in glucose (39%). In addition, the
amount of cFA and the other types of fatty acid (i.e. tFA and MSFA) led to no great differences in glucose metabolism as compared with the
respective control group. These data support the hypothesis that glucose changes induced by a HSFA diet are a multifaceted abnormality. Glucose
and lactate transport and intracellular glucose metabolism could be the key biochemical defects involved in this detrimental effect on glucose
metabolism.
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Many epidemiological and experimental studies (Lichtenstein
et al. 1998; Grundy et al. 2002; Riccardi et al. 2004) suggest
that the amount and type of fats consumed influence the devel-
opment and subsequent progression of several major diseases,
including CHD, obesity, diabetes and cancer. It is widely
known that a high intake of saturated fatty acids (SFA) (Stor-
lien et al. 1991; Alsaif & Duwaihy, 2004) and trans fatty acids
(tFA) (Clevidence et al. 1997; Ascherio et al. 1999) has an
adverse impact on the plasma lipid profile, and increases the
risk of developing CVD and type 2 diabetes.
The effect of diets high in fatty acids on glucose metab-
olism in human subjects and in experimental animal models
is well documented in the literature. For example, Uusitupa
et al. (1994) reported that in normal female subjects a high-
fat diet (total fat energy 40%) reduces the glucose tolerance;
similarly, in their thorough review Lichtenstein & Schwab
(2000) showed that impaired glucose tolerance and insulin
resistance are induced by high-fat feeding in experimental ani-
mals. Such effects are also influenced by the dietary fatty acid
composition. Animals fed on high-SFA diets develop glucose
intolerance (Wang et al. 2002) and impairment of insulin
action in both skeletal muscle and liver (Storlien et al.
1991; Oakes et al. 1997). Kim et al. (1996) reported that
when rats are fed a high-saturated fat diet, glycolysis is sup-
pressed and glycogen synthesis is altered in skeletal muscle.
They hypothesised that these changes might lead to the devel-
opment of insulin resistance. However, whereas n-3 PUFA
improve insulin action, n-6 PUFA have a slight negative
impact on insulin sensitivity (Storlien et al. 1991; Mohan &
Das, 2001; Taouis et al. 2002).
Several studies (Judd et al. 1994; Zock & Katan, 1997) have
shown that tFA increase both total and LDL-cholesterol
levels, resembling some of the dietary high proportion of
SFA (HSFA) effects. Although a number of conflicting results
have been described, some studies indicate that tFA decreases
HDL-cholesterol (Judd et al. 1994) and increases plasma lipo-
protein (a) levels (Aro et al. 1997). The specific effect of diet-
ary tFA on the glucose metabolic pathway, as compared with
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SFA and/or cis fatty acid (cFA) at high fat levels, has not been
determined. Dietary tFA might exert different effects on the
glucose oxidation pathway, as they do on lipid metabolism.
In this regard, Louheranta et al. (1999) showed that a tFA
diet has no effect on glucose and insulin metabolism as com-
pared with a MUFA diet in young healthy women. Alterna-
tively, Alstrup et al. (1999) demonstrated that in mouse b
cells tFA potentiates glucose-stimulated insulin secretion
more than cFA of the same carbon-chain length. This is prob-
ably due to a differential effect on glucose oxidation. Cromer
et al. (1995) demonstrated that tFA might inhibit glucose oxi-
dation in adipocytes isolated from rats.
Therefore, high levels of dietary fatty acid might alter glu-
cose tolerance. This effect appears to be dependent on the type
of fatty acid. We can also assume that a suppression of intra-
cellular glucose metabolism by competition for substrate oxi-
dation might precede and/or cause insulin resistance in
skeletal muscle. On the basis of these assumptions, we
aimed to evaluate the glucose metabolites and some key
enzyme activities involved in skeletal muscle and liver glu-
cose metabolism on an experimental animal model. The vari-
ables were: (1) the amount of dietary cFA; (2) the isomers
(trans or cis) and/or the degree of saturation (high or moder-
ate) of dietary fat.
Materials and methods
Materials
Nutrients for diet preparations were chemical grade, with the
exception of maize oil (Mazola, Argentina), sucrose, cellulose,
and maize starch, which were commercial grade obtained
from a local source. The same maize oil was used to prepare
both isomerised and saturated fats, as previously described
(Colandre´ et al. 2003). Biochemical reagents, enzymes and
standards were purchased from Sigma Chemical Co. (St
Louis, MO, USA) or Roche Molecular Biochemicals (Barce-
lona, Spain). Plasma glucose kits were purchased from
Wiener Co. (Rosario, Argentina). Catalytic palladium in char-
coal was from Alpha Aesar Co. (Ward Hill, MA, USA). Sol-
vents and reagents used for quantifying fatty acids were
chromatography grade. All the other chemicals used were of
the highest analytical grade.
Animals, diets and tissue preparation
All the animal studies were conducted in accordance with the
principles of our School of Biochemistry regulations, com-
piled using the Guide to the Care and Use of Experimental
Animals of the Laboratory (Institute of Laboratory Animal
Resources et al. 1996). Male Wistar rats weighing 80–100 g
were supplied by the Comisio´n Nacional de Energı´a Ato´mica
(Buenos Aires, Argentina). They were housed in animal quar-
ters under controlled conditions (23 ^ 28C and 12 h light–
dark cycle) in individual cages. The animals had free access
to water and a standard diet until reaching a weight of
120–130 g. After this, they were randomly divided into five
weight-matched groups and fed each diet ad libitum for 30 d.
All diets were nutritionally adequate and differed either in
the amount of cFA, or in the fatty acid composition
(Table 1). The control diet was based on the American Insti-
tute of Nutrition Ad Hoc Committee recommendation
(AIN-93G diet formulated for the growth, pregnancy and lac-
tation phases of rodents; Reeves et al. 1993). It contained 70 g
fat/kg. All other diets were enriched by replacing carbohydrate
with fat, to attain 200 g/kg (38·5% energy as fat). These
enriched fat diets contained 30 g maize oil/kg to exceed the
essential fatty acid recommendations, and fats with different
compositions (170 g/kg). The cFA diet was enriched
with 170 g cFA/kg (from maize oil). The tFA diet was
enriched with isomerised maize oil (170 g/kg) containing
300 g tFA/kg. The moderate proportion of SFA (MSFA) diet
was enriched with MSFA based on a blend of maize oil
(119 g/kg) and hydrogenated maize oil (59 g/kg), and the
HSFA diet was enriched with SFA from hydrogenated
maize oil (170 g/kg).
The preparation of the experimental dietary fats and the
methodology for evaluating their fatty acid composition was
recently described (Colandre´ et al. 2003). The fatty acid com-
position of the experimental fats used is shown in Table 2.
Each diet was freshly prepared every 3 d during the exper-
imental period.
Body weight and food consumption were measured
throughout the experimental period. After 30 d of dietary treat-
ment, rats were anaesthetised with acepromazine (1mg/kg
body weight) and ketamine (100mg/kg body weight) and
blood was collected in heparinised tubes. After blood
Table 1. Composition of the experimental diets*
Ingredient Control diet cFA diet tFA diet MSFA diet HSFA diet
Maize starch (g/kg diet) 529·5 399·5 399·5 399·5 399·5
Casein (g/kg diet) 200 200 200 200 200
Sucrose (g/kg diet) 100 100 100 100 100
Maize oil (g/kg diet) 70 200 30 149 30
Isomerised maize oil (g/kg diet) – – 170 – –
Hydrogenated maize oil (g/kg diet) – – – 51 170
Fibre (g/kg diet) 50 50 50 50 50
Mineral mixture (g/kg diet) 35 35 35 35 35
Vitamin mixture (g/kg diet) 10 10 10 10 10
L-Cystine–L-methionine (g/kg diet) 3·0 3·0 3·0 3·0 3·0
Choline (g/kg diet) 2·5 2·5 2·5 2·5 2·5
Energy (kJ/100 g) 1656·9 1928·8 1928·8 1928·8 1928·8
cFA, cis fatty acid; tFA, trans fatty acid; MSFA, moderate level of saturated fatty acid; HSFA, high level of saturated fatty acid.
* Vitamin and mineral mixtures were prepared according to Reeves et al. (1993).
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collection, samples of gastrocnemius muscle and liver were
taken. Plasma was separated by centrifugation at 3000 g for
10min. Sample tissues were immediately frozen at 2808C
and stored until analysis. For glycolytic metabolites and
enzyme analysis, a portion of each sample was lyophilised
and stored under dry conditions at 2208C.
Analysis of muscle and liver glycogen concentrations
Glycogen was extracted from about 4–5mg dry tissue by acid
treatment at 1008C (Adamo & Graham, 1998). The glucose
produced was measured using the enzymic method with fluori-
metric techniques (Lowry & Passonneau, 1972).
Analysis of metabolite concentrations
Plasma glucose levels were determined using commercial kits
(Wiener, Rosario, Argentina).
ATP, creatine, phosphate creatine, glucose, glucose-6-
phosphate (G-6-P), glucose-1-phosphate (G-1-P), fructose-6-
phosphate (F-6-P), fructose-1,6-bisphosphate (F-1,6-P2),
dihydroxyacetone-phosphate, glyceraldehyde-3-phosphate, lac-
tate, pyruvate and citrate were extracted by acid treatment from
3–5mg dry muscle and liver tissue in ice-cold 0·5 M-perchloric
acid. After centrifugation and neutralisation, samples of the
extracts were used. Measurements were carried out using
enzymatic methods with fluorimetric techniques (Lowry &
Passonneau, 1972).
About 5–10mg dry tissue powder was homogenised in 5
volumes of 50mM-NaOH and kept at 908C for 10min. The
extracts were neutralised with ice-cold acetic acid and the sol-
uble materials were used to measure fructose-2,6-bisphosphate
(F-2,6-P2) (van Schaftingen et al. 1982) and glucose-1,6-
bisphosphate (G-1,6-P2) (Passonneau et al. 1969). To
minimise the effect of blood and connective tissue on the
freeze-dried tissue, the total creatine content (sum of
phosphate creatine and creatine) for a given individual
sample was determined. It was then used to adjust individual
metabolite concentrations (Sabina et al. 1984).
Determination of liver and muscle triacylglycerol content
Fresh liver and muscle tissue samples were homogenised in 10
volumes of saline solution and used to measure triacylgly-
cerol, by the method of Laurell (1966).
Analysis of enzyme activities
Powdered muscle and liver were homogenised in 70 volumes
(w/v) of ice-cold extraction buffer (containing 50mM-tri(hy-
droxymethyl)-aminomethane-HCl, 4mM-EDTA, 30mM-KF,
30mM-b-mercaptoethanol; pH 7·0). The homogenate was
centrifuged at 12 000 g for 15min at 48C and the supernatant
fraction was used to measure the activities of 6-phospho-
fructo-1-kinase (PFK-1) (Cadefau et al. 1990). Citrate
synthase activity in liver and muscle was assessed according
to Bass et al. (1969).
Statistics
We used the unpaired Student’s t test to determine the statisti-
cal differences between dietary levels of cis unsaturated fats
(control diet v. cFA diet). Comparisons of fatty acid compo-
sition at high level of dietary fats (200 g/kg) were established
by one-way ANOVA (1 £ 4). When ANOVA showed signifi-
cant differences between dietary groups, the Tukey test was
performed. All differences were considered significant at
P,0·05. Values are expressed as means with their standard
errors of five or six animals per group.
Results
No differences could be observed between the diets in either
average daily food energy intake (control diet 273·6 (SE
13·1) kJ/d, cFA diet 265·0 (SE 6·8) kJ/d, tFA diet 247·7 (SE
4·2) kJ/d, MSFA diet 254·9 (SE 11·5) kJ/d, HSFA diet 270·7
(SE 21·2) kJ/d; P.0·05) or body-weight gain (control diet
133·9 (SE 6·6) g/30 d, cFA diet 139·2 (SE 4·1) g/30 d, tFA
diet 136·3 (SE 4·3) g/30 d, MSFA diet 133·6 (SE 6·5) g/30 d,
HSFA diet 138·7 (SE 4·3) g/30 d; P.0·05). No differences
could be found between the groups in the levels of metabolites
related to the energetic content of the tissues, specifically ATP
in muscle and liver and total creatine in muscle (Table 3).
These metabolites also reflected storage conditions and
manipulation of the samples.
When levels of cFA were considered, no differences were
found in plasma glucose concentrations under fasted con-
ditions, or in muscle and liver triacylglycerol content
(Table 3). However, the type of fatty acid in the high-fat
diets affected plasma glucose concentrations and muscle tri-
acylglycerol content. These were both higher in the HSFA
diet (P,0·05 v. cFA). Liver triacylglycerol content was
higher in tFA, MSFA and HSFA diets (P,0·05 v. cFA).
Compared with the recommended levels of fat, high levels
of cFA significantly decreased pyruvate concentration and
increased F-6-P, G-1,6-P2 and F-2,6-P2 in muscle (Table 4).
No differences were observed in all the other metabolites
Table 2. Fatty acid composition of experimental fats
(Mean values)
Experimental maize oil (weight percentage
(w/w) of the total fatty acid methyl esters)
Fatty acids Non-treated Isomerised Hydrogenated
16 : 0 10·78 10·87 11·23
c 16 : 1 0·20 0·10 0·15
18 : 0 2·24 2·61 59·33
t 18 : 1 ND 26·47 10·47
c18 : 1 31·36 25·41 17·22
t,t 18 : 2 ND 2·09 ND
t,c18 : 2 þ c, t 18 : 2 0·48 1·35 ND
c,c18 : 2 52·85 29·57 0·50
t,c,c18 : 3 0·06 0·03 ND
c,c,c18 : 3 0·75 0·41 ND
20 : 0 0·52 0·52 0·68
t 20 : 1 0·12 0·07 ND
c 20 : 1 0·24 0·13 0·22
22 : 0 0·20 0·18 0·12
24 : 0 0·20 0·19 0·08
% Trans fatty acids 0·66 30·00 10·47
% Saturated fatty acids 13·94 14·38 71·44
c, cis; t, trans; ND, not detected.
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analysed in muscle or liver. In addition, no changes in muscle
PFK-1 and citrate synthase or in hepatic PFK-1 and citrate
synthase activities were observed after 30 d of the high-
cFA-level diet.
The effects of different compositions of fatty acids at high
fat levels on muscle and liver metabolites are shown in Fig. 1,
Fig. 2, Fig. 3 and Fig. 4. Thus, Fig. 1 shows a significant
reduction in glucose levels and a significant increase of G-6-
P, F-6-P and F-1,6-P2 in the gastrocnemius muscle of rats
fed a HSFA diet as compared with a cFA diet. In addition,
muscle G-6-P and F-6-P were increased in HSFA v. tFA and
v. MSFA diets; and muscle F-6-P in the HSFA diet v. the
MSFA diet. No differences were observed in muscle and
liver glucose, G-6-P, F-6-P and F-1,6-P2 between the cFA,
tFA and MSFA diets. In gastrocnemius muscle, the HSFA
diet significantly increased the G-1-P levels as compared
with any other type of high-fat-level diet. The glycogen
level was slightly reduced by the HSFA diet, reaching statisti-
cal significance only between the HSFA diet and the MSFA
diet (Fig. 2) in muscle. No differences were detected in hepa-
tic G-1-P and glycogen content between the high-dietary fat
groups. The HSFA diet increased the muscle pyruvate, lactate
and citrate levels v. cFA, tFA or MSFA diets. The tFA diet
increased the muscle pyruvate levels v. the cFA diet. Surpris-
ingly, the HSFA diet also significantly increased the citrate
levels in liver, with no changes in the other metabolites ana-
lysed (Fig. 3). G-1,6-P2 and F-2,6-P2 were not changed by
any type of fatty acid at high levels of fat intake either in
muscle or liver. However, in muscle both bisphosphorylated
sugars were significantly higher in HSFA diets with regard
to the control diet (Fig. 4).
Fig. 5 shows regulatory enzyme activities in the muscle and
liver of rats fed high fat levels with different compositions
of fatty acid. No differences in PFK-1 and citrate synthase
Table 3. Plasma glucose and triacylglycerol (TG), and ATP and creatine content in muscle and liver†
(Mean values with their standard errors of five or six animals per group)
Control diet cFA diet tFA diet MSFA diet HSFA diet
Mean SE Mean SE Mean SE Mean SE Mean SE
Plasma glucose (mM) 6·50 0·17 6·11 0·11 6·61 0·28 5·85‡ 0·22 7·56* 0·44
Gastrocnemius TG (mmol/g wet tissue) 1·45 0·34 1·86 0·04 2·40 0·57 1·50 0·04 2·77* 0·21
Liver TG (mmol/g wet tissue) 8·10 0·06 8·02 0·71 17·09* 1·48 14·27* 1·38 13·29* 0·89
Gastrocnemius ATP (mmol/g dry tissue) 25·56 1·62 28·50 2·44 26·56 2·15 25·92 1·25 26·59 1·07
Liver ATP (mmol/g dry tissue) 7·08 0·39 6·79 0·31 7·11 0·31 7·44 0·25 8·25 0·26
Gastrocnemius total creatine (mmol/g dry tissue) 119·7 4·4 115·5 6·1 117·5 3·2 113·7 5·9 115·9 2·9
cFA, cis unsaturated fatty acid; tFA, trans unsaturated fatty acid; MSFA, moderate saturated fatty acid; HSFA, high saturated fatty acid.
* Mean value was significantly different from that for the cFA diet (P,0·05).
† The comparison of cis fatty acid levels was not significantly different, by unpaired Student’s t test, at P,0·05. Comparison of fatty acid composition at high dietary fat levels
was established by ANOVA (1 £ 4) followed by the Tukey test. For details, see p. 949.
‡ n 3.
Table 4. Effect of cis unsaturated fat level on glycolytic metabolites contents and enzyme activities in the muscle and liver
(Mean values with their standard errors of five or six animals)
Muscle Liver
Control diet† cFA diet‡ Control diet† cFA diet‡
Mean SE Mean SE Mean SE Mean SE
Glycogen content (mmol glucose/g dry tissue) 125·9 3·3 131·7 4·5 887·1 76·0 793·2 46·8
Glucose content (mmol/g dry tissue) 2·91 0·36 2·88 0·32 26·3 1·4 25·4 2·2
G-1-P content (mmol/g dry tissue) 0·14 0·02 0·11 0·02 0·17 0·02 0·18 0·02
G-6-P content (mmol/g dry tissue) 0·71 0·16 1·12 0·13 1·39 0·16 1·02 0·08
F-6-P content (mmol/g dry tissue) 0·14 0·01 0·20* 0·02 0·38 0·04 0·26 0·02
F-1,6-P2 content (mmol/g dry tissue) 3·71 0·66 2·75 0·35 0·18 0·01 0·23 0·02
DHAP content (mmol/g dry tissue) 0·28 0·05 0·21 0·07 0·08 0·01 0·09 0·03
Gly-3-P content (mmol/g dry tissue) 0·04 0·01 0·03 0·01 0·05 0·01 0·06 0·01
Lactate content (mmol/g dry tissue) 6·27 0·59 4·98 0·40 19·4 1·50 18·6 1·8
Pyruvate content (mmol/g dry tissue) 0·34 0·03 0·22* 0·03 0·35 0·07 0·26 0·01
Citrate content (mmol/g dry tissue) 0·43 0·04 0·53 0·06 0·55 0·09 0·50 0·09
F-2,6-P2 content (nmol/g dry tissue) 4·27 0·27 6·57* 0·68 25·0 2·5 26·0 3·0
G-1,6-P2 content (nmol/g dry tissue) 233·4 41·3 455·7* 46·3 185·0 26·3 203·6 23·3
PFK-1 activity (U/g dry tissue) 196·9 10·3 196·2 19·7 3·19 0·23 3·14 0·17
Citrate synthase activity (U/g dry tissue) 62·6 6·8 64·5 6·3 18·1 0·9 17·9 1·8
cFA, cis unsaturated fatty acid; G-1-P, glucose-1-phosphate; G-6-P, glucose-6-phosphate; F-6-P, fructose-6-phosphate; F-1,6-P2, fructose-1,6-bisphosphate;
DHAP, dihydroxyacetone-phosphate; Gly-3-P, glyceraldehyde-3-phosphate; F-2,6-P2, fructose-2,6-bisphosphate; G-1,6-P2, glucose-1,6-bisphosphate; PFK-1,
6-phosphofructo-1-kinase.
* Mean value was significantly different from that for the control diet (P,0·05). For details, see p. 949.
† Dietary fat 70 g/kg
‡ Dietary fat 200 g/kg.
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activities in muscle and liver were observed between the diet-
ary groups. However, the muscle F-1,6-P2:F-6-P ratio, used as
an index of flux through PFK-1, was significantly reduced by
the HSFA diet, mainly with regard to the control diet. The
mean values of the F-1,6-P2:F-6-P ratio in gastrocnemius
muscle were: control diet, 26·5 (SE 1·21); cFA diet, 13·37
(SE 0·64) (P,0·05 v. control diet); tFA diet, 18·31 (SE
2·37); MSFA diet, 12·69 (SE 0·90) (P,0·05 v. control diet);
HSFA diet, 5·80 (SE 1·09) (P,0·05 v. control diet).
Discussion
Dietary fats have been shown to lead to insulin resistance
(Storlien et al. 1997) and glucose metabolism changes. It is
widely recognised that both the amount and type of dietary
fatty acids modify insulin sensitivity in the muscle and liver
of experimental animals (Storlien et al. 1986). In addition,
intracellular glucose metabolism suppression might precede
and/or cause insulin resistance in the skeletal muscle of
rats fed a high-fat diet (Kim et al. 2000). In view of these
assumptions, we evaluated the glucose metabolites and key
enzyme activities in skeletal muscle and liver on an exper-
imental dietary model. The variables were: (1) the amount
of dietary cFA; (2) the isomers (trans or cis) and/or the satur-
ation of fatty acid at high dietary fat levels.
The levels of dietary cFA did not change the muscle and
liver triacylglycerol content under our experimental con-
ditions. In addition, dietary cFA levels did not lead to pro-
nounced changes in glucose metabolism. The most
remarkable changes at high levels of cFA are the increases
in F-6-P, F-2,6-P2 and G-1,6-P2 in muscle. High levels of
the allosteric activators of PFK-1 (F-2,6-P2 and G-1,6-P2)
could maintain the glycolytic pathway, increasing muscle glu-
cose utilisation. On the other hand, citrate, an allosteric inhibi-
tor of PFK-1, is not influenced by dietary levels of cFA.
Our most striking finding is that the type of dietary fatty
acid, rather than the level of fat content per se, may be a deci-
sive factor in the detrimental effects of dietary fat on muscle
glucose metabolites. Animals fed the HSFA diet showed sig-
nificantly increased muscle triacylglycerol content associated
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Fig. 1. Glucose (A), glucose-6-phosphate (G-6-P) (B), fructose-6-phosphate (F-6-P) (C) and fructose-1,6-bisphosphate (F-1,6-P2) (D) content in the muscle and
liver of animals fed high levels of fat. Values are means of five to six animals, with their standard errors represented by vertical bars. (A), Cis unsaturated fatty
acid diet; (q), trans unsaturated fatty acid diet; (o), moderate-saturated fatty acid diet; (B), high-saturated fatty acid diet (see p. 949). a,b Mean values with unlike
letters were significantly different (P,0·05) by Tukey’s test, after significant differences were found by one-way ANOVA (1 £ 4).
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Fig. 2. Glucose-1-phosphate (G-1-P) (A) and glycogen (B) content in the muscle and liver of animals fed high levels of fat. Values are means of five to six animals,
with their standard errors represented by vertical bars. (A), Cis unsaturated fatty acid diet; (q), trans unsaturated fatty acid diet; (o), moderate-saturated fatty acid
diet; (B), high-saturated fatty acid diet (see p. 949). a,b Mean values with unlike letters were significantly different (P,0·05) by Tukey’s test, after significant differ-
ences were found by one-way ANOVA (1 £ 4).
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with significantly elevated plasma glucose levels, and with
changes in muscle glucose metabolites. Thus, the high levels
of muscle G-6-P, G-1-P, F-6-P, F-1,6-P2, glyceraldehyde-3-
phosphate, lactate, pyruvate and citrate in rats fed a HSFA
diet are associated with low muscle glucose and normal
glycogen muscle stores, and reveal a glucose metabolic
defect. Several mechanisms might partially explain the impair-
ment of glucose metabolism. If the intracellular glucose–fatty
acid cycle (Randle et al. 1963) is operating in gastrocnemius
muscle, the high availability and oxidation of muscle triacyl-
glycerol content in a HSFA diet could lead to increased
levels of acetyl CoA. In turn, this could reduce the pyruvate
dehydrogenase activity, and therefore increase the pyruvate
and lactate levels in rats fed a HSFA diet. It has been
shown that a high-fat diet significantly increases pyruvate
dehydrogenase kinase-4 isoform expression, with a corre-
sponding decrease in pyruvate dehydrogenase activity (Pehle-
man et al. 2005). The inhibition of pyruvate dehydrogenase
activity could be at least partly responsible for the increases
in intermediary glycolytic metabolites, including glycerol-3-
phosphate. Since glycerol-3-phosphate is a regulatory metab-
olite in triacylglycerol synthesis (Maggs et al. 1995), it is
reasonable to suggest that raised levels of glycerol-3-phos-
phate could increase triacylglycerol synthesis, impairing the
glucose metabolism. The higher availability and probably
the oxidation of triacylglycerol in the muscle of HSFA-fed
animals could also increase the muscle citrate levels, thereby
reducing the PFK-1 and hexokinase activities. The very low
F-1,6-P2:F-6-P ratio in the HSFA diet indicates that flux
through PFK-1 is reduced. The high citrate level and the
acidic environment caused by lactate production might coun-
teract the effect of PFK-1 activation by bisphosphorylated
sugars (Andre´s et al. 1990).
The elevated levels of plasma glucose, associated with low
glucose concentration in gastrocnemius muscle, might suggest
a deficiency in glucose transport in the muscle of rats fed a
HSFA diet. These data are clearly consistent with a reduction
of GLUT-4 gene expression in the muscle of animals fed 80%
fat (% energy) for 7 weeks described by Kahn & Pedersen
(1993). In addition, a HSFA diet might inhibit the GLUT by
increasing muscle diacylglycerol concentrations (Montell
et al. 2001). Thus, in the presence of increased levels of
fatty acids, a high concentration of diacylglycerol activates a
protein kinase (protein kinase C-u), causing the serine phos-
phorylation of insulin receptor substrate-1 (Yu et al. 2002).
Serine phosphorylated insulin receptor substrate-1 cannot
recruit phosphatidyl-inositol-3-kinase and thus inhibits
GLUT-4 translocation.
The huge accumulation of muscle lactate does not exclude
the possibility that both an overproduction of lactate and a
decrease in trans-sarcolemmal lactate transport could be pre-
sent, as was described in experimental diabetes induced by
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streptozotocin (Py et al. 2001). Moreover, Storlien et al.
(1996) described changes in the fatty acid composition of
membrane phospholipids induced by a HSFA diet. These
alterations could affect membrane fluidity or permeability,
supporting the plausible theory that there is a decrease in glu-
cose and/or lactate transport.
In agreement with data recently reported by our group
(Colandre´ et al. 2003), HSFA increased liver triacylglycerol
content. However, this significant shift did not impact on the
hepatic glucose metabolism to the same extent as observed
in muscle. The significant increase in hepatic citrate levels
with a HSFA diet seems to have a negligible impact on the
glycolytic pathway after 30 d of feeding. It is not known
whether feeding a HSFA diet for longer periods would lead
to other hepatic metabolic disorders.
To our knowledge, the present study is the first to report the
effect of dietary tFA at high fat levels on glucose metabolites
in the muscle and liver of experimental animals. A noteworthy
aspect of the present study is the very little impact of the
muscle glucose metabolites to high fat levels enriched with
tFA as compared with HSFA. Thus, by reinforcing the key
role of the high muscle lipids availability and oxidation as a
driving force to the muscle glucose metabolism alterations
in a HSFA diet, we found that rats fed high levels of tFA
resulted in normal gastrocnemius muscle triacylglycerol
content and thereby in a lack of glucose metabolite alterations
in this muscle. In contrast, a tFA (as HSFA) diet led to
a significant accumulation of liver triacylglycerol content,
without any significant changes in hepatic glucose metab-
olism. Moreover, these experimental data may be consistent
with previous results from Louheranta et al. (1999), in
which a tFA diet in young healthy women resulted in changes
in the plasma lipid profile, with no changes in glucose and
insulin metabolism. On the other hand, Alstrup et al. (1999)
found that tFA potentiate glucose-stimulated insulin secretion
more than the corresponding cis isomers.
Finally, the high-fat-level MSFA diet had a lesser effect on
muscle and liver glucose metabolism. This might indicate that
a certain level of dietary SFA has to be reached to induce glu-
cose metabolic changes. Alternatively, dietary cFA might
counteract the negative impact of SFA on glucose metabolism.
If the latter is true, these results might provide some evidence
of the advantageous effect of replacing SFA with cFA.
In short, under our experimental conditions, dietary fats had
greater detrimental effects on glucose metabolism in muscle
than in liver. The type of dietary fatty acid rather than the
level of dietary fat content had an impact on muscle glucose
metabolism. Glycolytic changes induced by the HSFA diet
in muscle were a multifaceted abnormality. Glucose and lac-
tate transport and intracellular glucose metabolism could
play a key role in the biochemical defects involved in the det-
rimental effect of an HSFA diet on glucose metabolism. Diet-
ary tFA had a slight effect on glucose metabolism compared
with the HSFA diet.
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